Beth A. Malow, MD, MS, Robert L. Findling, MD, MBA, Carmen M. Schroder, MD, PhD, Athanasios Maras, MD, John Breddy, MSc, Tali Nir, DVM, Nava Zisapel, PhD, Paul Gringras, MD, MRCPCH 

This study demonstrates the safety of melatonin, a hypnotic (sleep) medication, in children with Autism Spectrum Disorder (ASD). It adds to the limited evidence base regarding effective medications for this group.

https://www.jaacap.org/article/S0890-8567(20)30034-4/fulltext?dgcid=raven_jbs_etoc_email